US Broker Ratings

Encompass Health Corporation (EHC) Stock Analysis: A 36% Upside Potential with Strong Buy Ratings

Encompass Health Corporation (NYSE: EHC) is making waves in the healthcare sector, presenting an intriguing investment opportunity with a compelling 36.34% potential upside, according to current analyst ratings. With all..

Alcon Inc. (ALC) Stock Analysis: Is a 14.57% Upside Within Reach for This Healthcare Giant?

Alcon Inc. (ALC), a prominent player in the healthcare sector, is capturing the interest of investors with the potential for a substantial upside of 14.57%. As a Swiss-based company specializing..

Haleon plc (HLN) Stock Analysis: Exploring a 19.3% Potential Upside in the Healthcare Sector

Haleon plc (HLN), a prominent player in the healthcare sector, has been drawing attention from investors with its diverse portfolio of consumer healthcare products. Headquartered in Weybridge, United Kingdom, Haleon..

Danaher Corporation (DHR) Stock Analysis: Healthcare Giant’s 9.51% Upside and Strong Buy Consensus

Danaher Corporation (NYSE: DHR) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $170.69 billion, the company is..

BioNTech SE (BNTX) Stock Analysis: Exploring a 39.63% Potential Upside in the Biotechnology Sector

BioNTech SE (BNTX), a prominent player in the biotechnology sector, has captured investor attention with its innovative strides in immunotherapy and a promising potential upside of 39.63%. As the company..

Astrazeneca PLC (AZN)

⚠️ No article content returned.

..

DexCom, Inc. (DXCM) Investor Outlook: 26.63% Potential Upside and Strong Buy Ratings

DexCom, Inc. (DXCM), a frontrunner in the healthcare sector specializing in medical devices, is gaining attention among investors with its robust growth trajectory and significant market presence. With a market..

Genmab A/S (GMAB) Stock Analysis: Unpacking the 10.37% Upside Potential for Biotech Investors

As one of the standout players in the biotechnology sector, Genmab A/S (GMAB) continues to capture the attention of investors with its promising product pipeline and strategic collaborations. With a..

ResMed Inc. (RMD) Stock Analysis: Exploring a 15.58% Upside Potential Amid Robust Healthcare Innovations

ResMed Inc. (NYSE: RMD) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a sizable market capitalization of $36.85 billion, the..

Quest Diagnostics (DGX) Stock Analysis: Promising 13.54% Upside Potential for Healthcare Investors

Quest Diagnostics Incorporated (NYSE: DGX), a key player in the healthcare sector under the diagnostics and research industry, stands out with its formidable $19.51 billion market capitalization. Based in Secaucus,..

Thermo Fisher Scientific Inc (TMO): Investor Outlook on Its 5% Potential Upside and Robust Analyst Ratings

For investors eyeing the healthcare sector, Thermo Fisher Scientific Inc (NYSE: TMO) offers a compelling mix of growth potential and stability. As a leader in the diagnostics and research industry,..

Tenet Healthcare Corporation (THC) Stock Analysis: An Investor’s Insight into Its 17.53% Potential Upside

Tenet Healthcare Corporation (NYSE: THC), a notable player in the healthcare sector, presents a compelling case for investors interested in the medical care facilities industry. With a robust market capitalization..

The Cooper Companies, Inc. (COO) Stock Analysis: Healthcare Leader Eyes 9% Upside Potential

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the medical instruments and supplies industry, is garnering attention from investors due to its steady performance and potential for growth...

Incyte Corporation (INCY) Stock Analysis: Strong Revenue Growth and Strategic Developments in the Biotech Sector

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology industry, continues to capture the attention of investors with its robust pipeline of therapeutics and impressive revenue growth. Headquartered in..

Gilead Sciences, Inc. (GILD) Stock Analysis: Strong Buy Ratings and 10.84% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD), a prominent player in the healthcare sector, particularly within the drug manufacturing industry, has been a focal point for investors seeking robust opportunities in biopharmaceuticals...

Summit Therapeutics Inc. (SMMT): Investor Outlook on a Biotech Stock with 66.79% Upside Potential

Summit Therapeutics Inc. (NASDAQ: SMMT) stands out in the biotech sector with its focus on pioneering medicinal therapies, including its lead candidate, ivonescimab, which is in Phase III trials for..

IQVIA Holdings, Inc. (IQV): Investor Outlook Reveals 6.22% Potential Upside with Strong Buy Ratings

IQVIA Holdings, Inc. (IQV), a prominent player in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth prospects. As a key representative in..

Zoetis Inc. (ZTS) Stock Analysis: Exploring 24.41% Potential Upside with Strong Buy Ratings

Zoetis Inc. (NYSE: ZTS), a leader in animal health, has been making headlines in the healthcare sector with its solid market presence and consistent product innovation. As a top player..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A Promising 10% Upside Potential

Teva Pharmaceutical Industries (NYSE: TEVA), a prominent player in the healthcare sector, commands attention from investors with its substantial market capitalization of $36.72 billion and a promising 10.33% potential upside...

Cardinal Health (CAH) Stock Analysis: A Leading Healthcare Distributor with a 10.49% Upside Potential

Cardinal Health, Inc. (NYSE: CAH), a stalwart in the healthcare services and medical distribution sector, stands as a prominent player with a substantial market capitalization of $47.78 billion. Headquartered in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds